Olokizumab superior to placebo and noninferior to adalimumab in RA patients Dr. Shravani Dali22 Sept 2022 8:30 PM ISTIn patients with rheumatoid arthritis who were receiving maintenance methotrexate, olokizumab was superior to placebo and noninferior to adalimumab...
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Study confirms long-term safety of hydroxychloroquine in Rheumatoid arthritis patients Dr. Kamal Kant Kohli4 Sept 2022 8:00 PM ISTWASHINGTON DC: Development of long QT syndrome was infrequent and not noticeably more frequent among American veterans receiving hydroxychloroquine...
Olokizumab Outperforms Placebo in RA patients on maintenance Methotrexate: NEJM Dr. Kamal Kant Kohli29 Aug 2022 8:00 AM ISTVIENNA: Patients with rheumatoid arthritis taking maintenance methotrexate respond better to olokizumab than to a placebo and non-inferior to...
Early Methotrexate initiation before patients develop rheumatism provides lasting relief: Lancet Dr. Kamal Kant Kohli15 Aug 2022 8:00 PM ISTEarly treatment benefits patients who have not fully developed rheumatoid arthritis but are in the preliminary stages of the disease. This is what...
Rate of infection with tofacitinib higher than TNF inhibitors among patients with RA Dr. Shravani Dali8 Aug 2022 10:00 AM ISTRates of infection with tofacitinib in rheumatoid arthritis are higher than with tumour necrosis factor (TNF) inhibitors according to a recent study...
Strides Pharma Science arm bags USFDA nod for Cyclosporine Softgel Capsules Ruchika Sharma3 Aug 2022 3:00 PM ISTThe product will be manufactured at the company's facility at Bengaluru and will be marketed by Strides Pharma Inc. in the US market.
Low-dose prednisolone effective in patients with established rheumatoid arthritis: study Dr. Shravani Dali19 July 2022 7:00 PM ISTAccording to a recent study published in the Annals of the Rheumatic Diseases, low-dose prednisolone is effective in treating patients with...
Novartis division Sandoz application for proposed biosimilar Hyrimoz's high concentration formulation accepted by EMA Ruchika Sharma19 Jun 2022 11:30 AM ISTUpon approval, the Hyrimoz (100 mg/mL) citrate-free HCF would offer reduced injection volume and potentially decrease the number of injections...
New population-based studies show increased risk of dementia and depression in RA Dr. Kamal Kant Kohli11 Jun 2022 9:00 AM ISTIn work presented at the 2022 EULAR Congress, Dr Jens Kristian Pedersen and colleagues used data from the DANBIO registry to describe the all-cause...
Favorable balance of benefits and harms of long-term steroid use in RA: GLORIA Trial Medha Baranwal7 Jun 2022 7:00 PM ISTNetherlands: Add-on low-dose prednisolone on standard treatment has beneficial long-term effects on damage progression and disease activity in older...
Antimalarials and electrocardiographic alterations: New data bring confidence Dr. Kamal Kant Kohli5 Jun 2022 8:00 PM ISTPrevious findings on the link between hydroxychloroquine and risk of arrhythmia have been contradictory, with low-level evidence-based results. To...
